Show simple item record

dc.contributor.authorMisra, S
dc.contributor.authorShields, B
dc.contributor.authorColclough, K
dc.contributor.authorJohnston, DG
dc.contributor.authorOliver, NS
dc.contributor.authorEllard, S
dc.contributor.authorHattersley, AT
dc.date.accessioned2016-08-09T08:51:52Z
dc.date.issued2016-07-19
dc.description.sponsorshipSM is funded by the Diabetes, Research and Wellness Foundation Sutherland Earl Clinical Research Fellowship. BS, KC, SE, and ATH are supported by the National Institute of Health Research (NIHR)-funded Exeter Clinical Research Facility. SE and ATH are Wellcome Trust Senior Investigators.en_GB
dc.identifier.doi10.1007/s00125-016-4056-7
dc.identifier.urihttp://hdl.handle.net/10871/22929
dc.language.isoenen_GB
dc.publisherSAGE Publicationsen_GB
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pubmed/27435864en_GB
dc.rightsThis is the author accepted manuscript. The final version is available from Springer Verlag via the DOI in this record.en_GB
dc.subjectGlucokinaseen_GB
dc.subjectHepatic nuclear factor 1 alphaen_GB
dc.subjectHepatic nuclear factor 4 alphaen_GB
dc.subjectMODYen_GB
dc.subjectSouth Asianen_GB
dc.titleSouth Asian individuals with diabetes who are referred for MODY testing in the UK have a lower mutation pick-up rate than white European peopleen_GB
dc.date.available2016-08-09T08:51:52Z
dc.identifier.issn0012-186X
dc.identifier.journalDiabetologiaen_GB
dc.identifier.pmcidPMC5016539


Files in this item

This item appears in the following Collection(s)

Show simple item record